Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Insmed Operating Margin 2010-2024 | INSM

Current and historical operating margin for Insmed (INSM) over the last 10 years. The current operating profit margin for Insmed as of December 31, 2024 is -251.24%.
  
Insmed Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2024-12-31 $0.36B $-0.88B -241.87%
2024-09-30 $0.34B $-0.83B -240.82%
2024-06-30 $0.33B $-0.76B -231.31%
2024-03-31 $0.32B $-0.71B -224.05%
2023-12-31 $0.31B $-0.71B -232.79%
2023-09-30 $0.28B $-0.68B -243.93%
2023-06-30 $0.27B $-0.66B -246.47%
2023-03-31 $0.26B $-0.52B -200.39%
2022-12-31 $0.25B $-0.46B -186.53%
2022-09-30 $0.24B $-0.41B -167.36%
2022-06-30 $0.22B $-0.38B -172.40%
2022-03-31 $0.20B $-0.38B -190.05%
2021-12-31 $0.19B $-0.38B -200.00%
2021-09-30 $0.17B $-0.37B -215.03%
2021-06-30 $0.17B $-0.32B -190.59%
2021-03-31 $0.17B $-0.29B -173.05%
2020-12-31 $0.16B $-0.27B -161.59%
2020-09-30 $0.17B $-0.22B -128.40%
2020-06-30 $0.16B $-0.22B -132.32%
2020-03-31 $0.15B $-0.23B -148.03%
2019-12-31 $0.14B $-0.24B -171.53%
2011-12-31 $0.00B $-0.06B -1525.00%
2011-09-30 $0.00B $-0.06B -1450.00%
2011-06-30 $0.01B $-0.02B -400.00%
2011-03-31 $0.01B $-0.02B -214.29%
2010-12-31 $0.01B $-0.01B -114.29%
2010-09-30 $0.01B $-0.00B -25.00%
2010-06-30 $0.01B $-0.00B -25.00%
2010-03-31 $0.01B $-0.00B -22.22%
2009-12-31 $0.01B $-0.01B -100.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $13.808B $0.364B
Insmed is a biopharmaceutical company engaged in the development and commercialization of ARIKAYCE, or liposomal amikacin for inhalation, for at least two identified orphan patient populations: patients with nontuberculous mycobacteria (NTM) lung infections and cystic fibrosis (CF) patients with Pseudomonas aeruginosa lung infections. Insmed is also focused on the development of INS1009, the company's inhaled treprostinil prodrug for the treatment of pulmonary arterial hypertension (PAH), a chronic, life-threatening disorder characterized by abnormally high blood pressure in the arteries between the heart and lungs.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $227.939B 17.88
Amgen (AMGN) United States $167.366B 15.72
Gilead Sciences (GILD) United States $139.520B 24.31
Vertex Pharmaceuticals (VRTX) United States $124.497B 0.00
Bristol Myers Squibb (BMY) United States $124.100B 53.50
GSK (GSK) United Kingdom $80.184B 9.59
CSL (CSLLY) Australia $76.573B 0.00
Regeneron Pharmaceuticals (REGN) United States $69.337B 15.98
Argenex SE (ARGX) Netherlands $35.962B 248.68
Alnylam Pharmaceuticals (ALNY) United States $35.126B 0.00
BeiGene (ONC) Cayman Islands $26.859B 0.00
BioNTech SE (BNTX) Germany $21.852B 0.00
Biogen (BIIB) United States $20.030B 8.31
Intra-Cellular Therapies (ITCI) United States $14.052B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.486B 25.99
Genmab (GMAB) Denmark $12.957B 15.79
Illumina (ILMN) United States $12.567B 32.38
Genmab (GNMSF) Denmark $12.541B 12.92
Incyte (INCY) United States $11.718B 356.18
Moderna (MRNA) United States $10.961B 0.00
Exelixis (EXEL) United States $10.333B 21.10
Swedish Orphan Biovitrum (BIOVF) Sweden $10.221B 26.10
Ascendis Pharma (ASND) Denmark $9.459B 0.00
Bio-Techne Corp (TECH) United States $9.269B 35.53
QIAGEN (QGEN) Netherlands $8.908B 17.96
Exact Sciences (EXAS) United States $8.041B 0.00
Halozyme Therapeutics (HALO) United States $7.883B 16.28
Jazz Pharmaceuticals (JAZZ) Ireland $7.540B 6.82
Roivant Sciences (ROIV) United Kingdom $7.200B 0.00
Repligen (RGEN) United States $7.144B 85.97
Bio-Rad Laboratories (BIO.B) United States $6.778B 23.47
Revolution Medicines (RVMD) United States $6.574B 0.00
Legend Biotech (LEGN) United States $6.231B 0.00
TG Therapeutics (TGTX) United States $6.193B 281.64
Sarepta Therapeutics (SRPT) United States $6.193B 29.14
Axsome Therapeutics (AXSM) United States $5.688B 0.00
Telix Pharmaceuticals (TLX) Australia $5.660B 0.00
Blueprint Medicines (BPMC) United States $5.656B 0.00
Alkermes (ALKS) Ireland $5.370B 13.65
Zealand Pharma (ZLDPF) Denmark $5.369B 0.00
Guardant Health (GH) United States $5.258B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $5.195B 0.00
Krystal Biotech (KRYS) United States $5.194B 54.31
Nuvalent (NUVL) United States $5.078B 0.00
Vaxcyte (PCVX) United States $4.862B 0.00
Cytokinetics (CYTK) United States $4.759B 0.00
ADMA Biologics Inc (ADMA) United States $4.690B 39.68
PTC Therapeutics (PTCT) United States $4.019B 0.00
Zai Lab (ZLAB) China $3.962B 0.00
Arcellx (ACLX) United States $3.604B 0.00
Avidity Biosciences (RNA) United States $3.549B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.400B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.349B 0.00
SpringWorks Therapeutics (SWTX) United States $3.307B 0.00
Akero Therapeutics (AKRO) United States $3.223B 0.00
Scholar Rock Holding (SRRK) United States $3.044B 0.00
Protagonist Therapeutics (PTGX) United States $2.969B 11.51
CRISPR Therapeutics AG (CRSP) Switzerland $2.919B 0.00
Alvotech (ALVO) Luxembourg $2.915B 0.00
Merus (MRUS) Netherlands $2.908B 0.00
Immunovant (IMVT) United States $2.903B 0.00
Metsera (MTSR) United States $2.859B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.770B 24.79
Apellis Pharmaceuticals (APLS) United States $2.745B 0.00
Viking Therapeutics (VKTX) United States $2.711B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.622B 0.00
ImmunityBio (IBRX) United States $2.569B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.568B 0.00
Amicus Therapeutics (FOLD) United States $2.507B 136.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.501B 0.00
Biohaven (BHVN) United States $2.454B 0.00
Twist Bioscience (TWST) United States $2.342B 0.00
Vericel (VCEL) United States $2.237B 247.89
Mirum Pharmaceuticals (MIRM) United States $2.208B 0.00
Belite Bio (BLTE) United States $2.108B 0.00
Edgewise Therapeutics (EWTX) United States $2.095B 0.00
Ligand Pharmaceuticals (LGND) United States $2.025B 0.00
Denali Therapeutics (DNLI) United States $1.974B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.971B 0.00
NovoCure (NVCR) Jersey $1.959B 0.00
Beam Therapeutics (BEAM) United States $1.949B 0.00
Ascentage Pharma Group - (AAPG) China $1.911B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.903B 13.22
CG Oncology (CGON) United States $1.867B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.856B 0.00
Kymera Therapeutics (KYMR) United States $1.778B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.749B 0.00
Disc Medicine (IRON) United States $1.716B 0.00
Bavarian Nordic (BVNRY) Denmark $1.706B 12.02
Apogee Therapeutics (APGE) United States $1.682B 0.00
Agios Pharmaceuticals (AGIO) United States $1.679B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.613B 0.00
Dynavax Technologies (DVAX) United States $1.609B 72.06
Janux Therapeutics (JANX) United States $1.596B 0.00
Certara (CERT) United States $1.594B 34.14
Travere Therapeutics (TVTX) United States $1.590B 0.00
Mesoblast (MESO) Australia $1.586B 0.00
Vera Therapeutics (VERA) United States $1.531B 0.00
MannKind (MNKD) United States $1.527B 31.44
Immunocore Holdings (IMCR) United Kingdom $1.484B 0.00
ANI Pharmaceuticals (ANIP) United States $1.458B 16.49
IDEAYA Biosciences (IDYA) United States $1.434B 0.00
Liquidia Technologies (LQDA) United States $1.258B 0.00
WAVE Life Sciences (WVE) Singapore $1.240B 0.00
NeoGenomics (NEO) United States $1.219B 0.00
Celldex Therapeutics (CLDX) United States $1.205B 0.00
Pacira BioSciences (PCRX) United States $1.150B 10.80
MiMedx (MDXG) United States $1.120B 26.21
BGM Group (BGM) China $1.112B 0.00
Adaptive Biotechnologies (ADPT) United States $1.104B 0.00
Viridian Therapeutics (VRDN) United States $1.098B 0.00
Iovance Biotherapeutics (IOVA) United States $1.092B 0.00
Anbio Biotechnology (NNNN) Germany $1.073B 0.00
89BIO (ETNB) United States $1.061B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.057B 0.00
Novavax (NVAX) United States $1.031B 0.00
Geron (GERN) United States $1.013B 0.00
Mineralys Therapeutics (MLYS) United States $0.997B 0.00
Structure Therapeutics (GPCR) United States $0.993B 0.00
Spyre Therapeutics (SYRE) United States $0.972B 0.00
Nurix Therapeutics (NRIX) United States $0.906B 0.00
Vir Biotechnology (VIR) United States $0.889B 0.00
GRAIL (GRAL) United States $0.866B 0.00
Oculis Holding AG (OCS) Switzerland $0.831B 0.00
Zymeworks (ZYME) United States $0.829B 0.00
Arcus Biosciences (RCUS) United States $0.825B 0.00
Pharvaris (PHVS) Netherlands $0.821B 0.00
Myriad Genetics (MYGN) United States $0.810B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.804B 0.00
Chimerix (CMRX) United States $0.798B 0.00
Praxis Precision Medicines (PRAX) United States $0.764B 0.00
Replimune (REPL) United States $0.751B 0.00
Intellia Therapeutics (NTLA) United States $0.736B 0.00
Anavex Life Sciences (AVXL) United States $0.730B 0.00
Gyre Therapeutics (GYRE) United States $0.723B 96.50
Rocket Pharmaceuticals (RCKT) United States $0.711B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.711B 0.00
Bicara Therapeutics (BCAX) United States $0.710B 0.00
LENZ Therapeutics (LENZ) United States $0.708B 0.00
Cogent Biosciences (COGT) United States $0.682B 0.00
Fortrea Holdings (FTRE) United States $0.681B 22.21
Arbutus Biopharma (ABUS) United States $0.668B 0.00
Prothena (PRTA) Ireland $0.666B 0.00
AbCellera Biologics (ABCL) Canada $0.665B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
ArriVent BioPharma (AVBP) United States $0.629B 0.00
CureVac (CVAC) Germany $0.620B 5.04
Trevi Therapeutics (TRVI) United States $0.608B 0.00
Pharming Group (PHGUF) Netherlands $0.604B 0.00
Nuvation Bio (NUVB) United States $0.596B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.588B 0.00
Immunome (IMNM) United States $0.585B 0.00
Dianthus Therapeutics (DNTH) United States $0.583B 0.00
GH Research (GHRS) Ireland $0.574B 0.00
UniQure (QURE) Netherlands $0.573B 0.00
AnaptysBio (ANAB) United States $0.570B 0.00
Pharming Group (PHAR) Netherlands $0.569B 0.00
Castle Biosciences (CSTL) United States $0.561B 32.29
Immatics (IMTX) Germany $0.538B 32.21
Niagen Bioscience (NAGE) United States $0.536B 172.50
MeiraGTx Holdings (MGTX) United States $0.535B 0.00
Kura Oncology (KURA) United States $0.533B 0.00
Opthea (OPT) Australia $0.525B 0.00
Cytek Biosciences (CTKB) United States $0.514B 0.00
Urogen Pharma (URGN) United States $0.510B 0.00
Tyra Biosciences (TYRA) United States $0.494B 0.00
Sage Therapeutics (SAGE) United States $0.489B 0.00
Arvinas (ARVN) United States $0.483B 0.00
Maze Therapeutics (MAZE) United States $0.482B 0.00
PureTech Health (PRTC) United States $0.475B 0.00
Sionna Therapeutics (SION) United States $0.462B 0.00
Cullinan Therapeutics (CGEM) United States $0.443B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.441B 0.00
Precigen (PGEN) United States $0.438B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.437B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.415B 0.00
Keros Therapeutics (KROS) United States $0.413B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.412B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.411B 0.00
CorMedix Inc (CRMD) United States $0.402B 0.00
Oric Pharmaceuticals (ORIC) United States $0.396B 0.00
Abivax SA (ABVX) France $0.396B 0.00
Erasca (ERAS) United States $0.388B 0.00
Kamada (KMDA) Israel $0.380B 25.42
Sana Biotechnology (SANA) United States $0.378B 0.00
Celcuity (CELC) United States $0.375B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.373B 0.00
Rapport Therapeutics (RAPP) United States $0.366B 0.00
Stoke Therapeutics (STOK) United States $0.360B 0.00
REGENXBIO (RGNX) United States $0.358B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.349B 0.00
Eton Pharmaceuticals (ETON) United States $0.348B 0.00
Cartesian Therapeutics (RNAC) United States $0.341B 0.00
Entrada Therapeutics (TRDA) United States $0.340B 4.73
Ginkgo Bioworks Holdings (DNA) United States $0.331B 0.00
Tectonic Therapeutic (TECX) United States $0.331B 0.00
Zenas BioPharma (ZBIO) United States $0.330B 0.00
Upstream Bio (UPB) United States $0.328B 0.00
Absci (ABSI) United States $0.320B 0.00
Northwest Biotherapeutics (NWBO) United States $0.318B 0.00
Allogene Therapeutics (ALLO) United States $0.317B 0.00
Palvella Therapeutics (PVLA) United States $0.314B 0.00
Verastem (VSTM) United States $0.310B 0.00
Benitec Biopharma (BNTC) United States $0.305B 0.00
Astria Therapeutics (ATXS) United States $0.301B 0.00
Aura Biosciences (AURA) United States $0.294B 0.00
Alumis (ALMS) United States $0.290B 0.00
MaxCyte (MXCT) United States $0.289B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.287B 0.00
Solid Biosciences (SLDB) United States $0.287B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.285B 0.00
Alpha Teknova (TKNO) United States $0.277B 0.00
ATyr Pharma (ATYR) United States $0.268B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.268B 0.00
Candel Therapeutics (CADL) United States $0.267B 0.00
Emergent Biosolutions (EBS) United States $0.264B 0.00
Compass Therapeutics (CMPX) United States $0.263B 0.00
Prime Medicine (PRME) United States $0.261B 0.00
Lifecore Biomedical (LFCR) United States $0.261B 0.00
2seventy Bio (TSVT) United States $0.259B 0.00
Septerna (SEPN) United States $0.257B 0.00
Olema Pharmaceuticals (OLMA) United States $0.257B 0.00
Prima BioMed (IMMP) Australia $0.256B 0.00
Atea Pharmaceuticals (AVIR) United States $0.256B 0.00
Bright Minds Biosciences (DRUG) United States $0.254B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.254B 0.00
Gossamer Bio (GOSS) United States $0.250B 0.00
ACELYRIN, INC (SLRN) United States $0.249B 0.00
MBX Biosciences (MBX) United States $0.247B 0.00
Terns Pharmaceuticals (TERN) United States $0.241B 0.00
XOMA Royalty (XOMA) United States $0.239B 0.00
Cidara Therapeutics (CDTX) United States $0.236B 0.00
Abeona Therapeutics (ABEO) United States $0.231B 0.00
Nuvectis Pharma (NVCT) United States $0.229B 0.00
EnGene Holdings (ENGN) Canada $0.228B 0.00
ITeos Therapeutics (ITOS) United States $0.228B 0.00
Codexis (CDXS) United States $0.223B 0.00
Monopar Therapeutics (MNPR) United States $0.222B 0.00
Design Therapeutics (DSGN) United States $0.219B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.217B 0.00
Humacyte (HUMA) United States $0.215B 0.00
Adocia (ADOCY) France $0.213B 0.00
Anika Therapeutics (ANIK) United States $0.213B 0.00
Annexon (ANNX) United States $0.212B 0.00
Cardiff Oncology (CRDF) United States $0.209B 0.00
Ocugen (OCGN) United States $0.206B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.203B 0.00
Foghorn Therapeutics (FHTX) United States $0.203B 0.00
Inhibrx Biosciences (INBX) United States $0.203B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.200B 0.00
Checkpoint Therapeutics (CKPT) United States $0.197B 0.00
Semper Paratus Acquisition (TVGN) United States $0.189B 0.00
AC Immune (ACIU) Switzerland $0.188B 0.00
CARGO Therapeutics (CRGX) United States $0.187B 0.00
Voyager Therapeutics (VYGR) United States $0.187B 0.00
Amarin (AMRN) Ireland $0.184B 0.00
Contineum Therapeutics (CTNM) United States $0.181B 0.00
INmune Bio (INMB) United States $0.179B 0.00
Rezolute (RZLT) United States $0.176B 0.00
Neurogene (NGNE) United States $0.175B 0.00
GENFIT S.A (GNFT) France $0.171B 0.00
Adherex Technologies (FENC) United States $0.168B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.163B 0.00
DiaMedica Therapeutics (DMAC) United States $0.162B 0.00
Neumora Therapeutics (NMRA) United States $0.162B 0.00
Rapt Therapeutics (RAPT) United States $0.161B 0.00
Aardvark Therapeutics (AARD) United States $0.161B 0.00
Molecular Partners AG (MOLN) Switzerland $0.157B 0.00
Third Harmonic Bio (THRD) United States $0.157B 0.00
Fulcrum Therapeutics (FULC) United States $0.155B 0.00
Inventiva S.A (IVA) France $0.154B 0.00
Innate Pharma S.A (IPHA) France $0.149B 0.00
Tango Therapeutics (TNGX) United States $0.148B 0.00
Kodiak Sciences (KOD) United States $0.148B 0.00
Sangamo Therapeutics (SGMO) United States $0.147B 0.00
Puma Biotechnology (PBYI) United States $0.147B 4.85
BioStem Technologies (BSEM) $0.144B 12.65
DBV Technologies S.A (DBVT) France $0.140B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.140B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.140B 0.00
TuHURA Biosciences (HURA) United States $0.137B 0.00
BioAge Labs (BIOA) United States $0.135B 0.00
ScPharmaceuticals (SCPH) United States $0.132B 0.00
Actuate Therapeutics (ACTU) United States $0.132B 0.00
Nkarta (NKTX) United States $0.131B 0.00
Compugen (CGEN) Israel $0.130B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.126B 0.00
Greenwich LifeSciences (GLSI) United States $0.125B 0.00
Seres Therapeutics (MCRB) United States $0.122B 0.00
Alector (ALEC) United States $0.122B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.117B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.114B 0.00
C4 Therapeutics (CCCC) United States $0.114B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.113B 0.00
Instil Bio (TIL) United States $0.113B 0.00
Nautilus Biotechnology (NAUT) United States $0.109B 0.00
Coya Therapeutics (COYA) United States $0.108B 0.00
Elutia (ELUT) United States $0.103B 0.00
BioHarvest Sciences (BHST) Canada $0.102B 0.00
Seer (SEER) United States $0.101B 0.00
Sagimet Biosciences (SGMT) United States $0.100B 0.00
XBiotech (XBIT) United States $0.099B 0.00
Immunic (IMUX) United States $0.098B 0.00
Galena Biopharma (SLS) United States $0.098B 0.00
Editas Medicine (EDIT) United States $0.096B 0.00
Coherus BioSciences (CHRS) United States $0.094B 0.00
Genelux (GNLX) United States $0.093B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.092B 0.00
Adverum Biotechnologies (ADVM) United States $0.091B 0.00
Fate Therapeutics (FATE) United States $0.091B 0.00
Vor Biopharma (VOR) $0.090B 0.00
Black Diamond Therapeutics (BDTX) United States $0.088B 0.00
Senti Biosciences (SNTI) United States $0.087B 0.00
Renovaro (RENB) United States $0.086B 0.00
Caribou Biosciences (CRBU) United States $0.085B 0.00
Advanced Biomed (ADVB) $0.085B 0.00
Exicure (XCUR) United States $0.084B 0.00
Zura Bio (ZURA) United States $0.084B 0.00
Kyverna Therapeutics (KYTX) United States $0.083B 0.00
Vigil Neuroscience (VIGL) United States $0.083B 0.00
Pliant Therapeutics (PLRX) United States $0.083B 0.00
Climb Bio (CLYM) United States $0.082B 0.00
Ventyx Biosciences (VTYX) United States $0.082B 0.00
Alpha Cognition (ACOG) Canada $0.081B 0.00
CAMP4 Therapeutics (CAMP) United States $0.081B 0.00
CervoMed (CRVO) United States $0.080B 0.00
TScan Therapeutics (TCRX) United States $0.078B 0.00
Entera Bio (ENTX) Israel $0.077B 0.00
Biomea Fusion (BMEA) United States $0.077B 0.00
Adlai Nortye (ANL) Cayman Islands $0.074B 0.00
Artiva Biotherapeutics (ARTV) United States $0.073B 0.00
Aerovate Therapeutics (AVTE) United States $0.073B 0.00
HilleVax (HLVX) United States $0.073B 0.00
Genenta Science S.p.A (GNTA) Italy $0.073B 0.00
Invivyd (IVVD) United States $0.073B 0.00
Rani Therapeutics Holdings (RANI) United States $0.072B 0.00
VistaGen Therapeutics (VTGN) United States $0.072B 0.00
IO Biotech (IOBT) Denmark $0.072B 0.00
Adagene (ADAG) China $0.072B 0.00
MediciNova (MNOV) United States $0.072B 0.00
Clearside Biomedical (CLSD) United States $0.071B 0.00
Akoya Biosciences (AKYA) United States $0.069B 0.00
Cellectis S.A (CLLS) France $0.069B 0.00
IGM Biosciences (IGMS) United States $0.069B 0.00
InflaRx (IFRX) Germany $0.068B 0.00
Cabaletta Bio (CABA) United States $0.068B 0.00
I-Mab (IMAB) China $0.067B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.067B 0.00
Citius Oncology (CTOR) United States $0.067B 0.00
Elicio Therapeutics (ELTX) United States $0.066B 0.00
EXoZymes (EXOZ) United States $0.065B 0.00
ZIVO Bioscience (ZIVO) United States $0.065B 0.00
Jasper Therapeutics (JSPR) United States $0.065B 0.00
Theratechnologies (THTX) Canada $0.064B 0.00
Adicet Bio (ACET) United States $0.062B 0.00
Ikena Oncology (IKNA) United States $0.062B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.061B 0.00
Scilex Holding (SCLX) United States $0.060B 0.00
Inovio Pharmaceuticals (INO) United States $0.060B 0.00
Quince Therapeutics (QNCX) United States $0.059B 0.00
Alto Neuroscience (ANRO) United States $0.058B 0.00
Inozyme Pharma (INZY) United States $0.058B 0.00
BeyondSpring (BYSI) United States $0.058B 0.00
OnKure Therapeutics (OKUR) United States $0.058B 0.00
Cue Biopharma (CUE) United States $0.058B 0.00
Applied Therapeutics (APLT) United States $0.057B 0.00
VTv Therapeutics (VTVT) United States $0.055B 0.00
Immuneering (IMRX) United States $0.055B 0.00
PDS Biotechnology (PDSB) United States $0.054B 0.00
Sutro Biopharma (STRO) United States $0.054B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.053B 0.00
Forte Biosciences (FBRX) United States $0.051B 0.00
CytomX Therapeutics (CTMX) United States $0.051B 1.67
Adaptimmune Therapeutics (ADAP) United Kingdom $0.051B 0.00
Aligos Therapeutics (ALGS) United States $0.050B 0.00
Kronos Bio (KRON) United States $0.050B 0.00
Tenaya Therapeutics (TNYA) United States $0.050B 0.00
Medicus Pharma (MDCX) Canada $0.050B 0.00
Skye Bioscience (SKYE) United States $0.049B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.048B 0.00
TELA Bio (TELA) United States $0.048B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.048B 0.00
Bluebird Bio (BLUE) United States $0.048B 0.00
Oncolytics Biotech (ONCY) Canada $0.048B 0.00
Immix Biopharma (IMMX) United States $0.047B 0.00
PepGen (PEPG) United States $0.046B 0.00
Shattuck Labs (STTK) United States $0.046B 0.00
Whitehawk Therapeutics (WHWK) United States $0.044B 0.00
Werewolf Therapeutics (HOWL) United States $0.044B 0.00
Fortress Biotech (FBIO) United States $0.043B 0.00
OKYO Pharma (OKYO) $0.043B 0.00
Mersana Therapeutics (MRSN) United States $0.043B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.043B 0.00
Repare Therapeutics (RPTX) Canada $0.042B 0.00
Celularity (CELU) United States $0.041B 0.00
X4 Pharmaceuticals (XFOR) United States $0.041B 0.00
AN2 Therapeutics (ANTX) United States $0.041B 0.00
Dyadic (DYAI) United States $0.041B 0.00
Kalaris Therapeutics (KLRS) United States $0.041B 0.00
Spero Therapeutics (SPRO) United States $0.040B 0.00
IBio (IBIO) United States $0.040B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.039B 0.00
Oncobiologics (OTLK) United States $0.039B 0.00
Rein Therapeutics (RNTX) United States $0.038B 0.00
Lantern Pharma (LTRN) United States $0.038B 0.00
Agenus (AGEN) United States $0.038B 0.00
Xilio Therapeutics (XLO) United States $0.038B 0.00
Precision BioSciences (DTIL) United States $0.037B 0.00
Radiopharm Theranostics - (RADX) $0.036B 0.00
Kezar Life Sciences (KZR) United States $0.036B 0.00
KALA BIO (KALA) United States $0.035B 0.00
Atara Biotherapeutics (ATRA) United States $0.035B 0.00
MiNK Therapeutics (INKT) United States $0.034B 0.00
Femasys (FEMY) United States $0.034B 0.00
Boundless Bio (BOLD) United States $0.034B 0.00
Estrella Immunopharma (ESLA) United States $0.034B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.033B 0.00
ALX Oncology Holdings (ALXO) United States $0.033B 0.00
Cadrenal Therapeutics (CVKD) United States $0.033B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.033B 0.00
FibroBiologics (FBLG) United States $0.033B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.032B 0.00
Opus Genetics (IRD) United States $0.031B 0.00
Alterity Therapeutics - (ATHE) Australia $0.031B 0.00
Connect Biopharma Holdings (CNTB) United States $0.030B 0.00
Pluri (PLUR) Israel $0.030B 0.00
Lexaria Bioscience (LEXX) Canada $0.030B 0.00
Intensity Therapeutics (INTS) United States $0.030B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.030B 0.00
Rallybio (RLYB) United States $0.027B 0.00
Generation Bio (GBIO) United States $0.027B 0.00
Clene (CLNN) United States $0.026B 0.00
Cognition Therapeutics (CGTX) United States $0.026B 0.00
Tenax Therapeutics (TENX) United States $0.026B 0.00
CalciMedica (CALC) United States $0.026B 0.00
Dare Bioscience (DARE) United States $0.025B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.024B 0.00
RenovoRx (RNXT) United States $0.024B 0.00
Cara Therapeutics (CARA) United States $0.023B 0.00
Longeveron (LGVN) United States $0.023B 0.00
Grace Therapeutics (GRCE) Canada $0.023B 0.00
LakeShore Biopharma (LSB) China $0.023B 0.00
Promis Neurosciences (PMN) Canada $0.023B 0.00
Ovid Therapeutics (OVID) United States $0.022B 0.00
Passage Bio (PASG) United States $0.022B 0.00
Abpro Holdings (ABP) United States $0.021B 0.00
Annovis Bio (ANVS) United States $0.021B 0.00
Allakos (ALLK) United States $0.021B 0.00
Lisata Therapeutics (LSTA) United States $0.020B 0.00
Q32 Bio (QTTB) United States $0.020B 0.00
Enzo Biochem (ENZ) United States $0.019B 0.00
Beyond Air (XAIR) United States $0.019B 0.00
Curis (CRIS) United States $0.018B 0.00
UNITY Biotechnology (UBX) United States $0.018B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.017B 0.00
Edesa Biotech (EDSA) Canada $0.017B 0.00
BioAtla (BCAB) United States $0.017B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.016B 0.00
Cingulate (CING) United States $0.016B 0.00
Chemomab Therapeutics (CMMB) Israel $0.016B 0.00
Imunon (IMNN) United States $0.015B 0.00
Bolt Biotherapeutics (BOLT) United States $0.015B 0.00
Elevation Oncology (ELEV) United States $0.015B 0.00
Quantum Biopharma (QNTM) Canada $0.015B 0.00
Synlogic (SYBX) United States $0.015B 0.00
Cocrystal Pharma (COCP) United States $0.014B 0.00
Equillium (EQ) United States $0.014B 0.00
ABVC BioPharma (ABVC) United States $0.014B 0.00
Moleculin Biotech (MBRX) United States $0.014B 0.00
BRIACELL THERAP (BCTX) Canada $0.014B 0.00
IN8bio (INAB) United States $0.013B 0.00
NextCure (NXTC) United States $0.013B 0.00
Biorestorative Therapies (BRTX) United States $0.013B 0.00
MetaVia (MTVA) United States $0.013B 0.00
HOOKIPA Pharma (HOOK) United States $0.013B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.013B 0.00
HCW Biologics (HCWB) United States $0.013B 0.00
Leap Therapeutics (LPTX) United States $0.013B 0.00
SAB Biotherapeutics (SABS) United States $0.013B 0.00
Spruce Biosciences (SPRB) United States $0.012B 0.00
BioCardia (BCDA) United States $0.012B 0.00
Affimed (AFMD) Germany $0.012B 0.00
Aprea Therapeutics (APRE) United States $0.011B 0.00
Athira Pharma (ATHA) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.010B 0.00
GeoVax Labs (GOVX) United States $0.010B 0.00
Sensei Biotherapeutics (SNSE) United States $0.010B 0.00
Gelteq (GELS) Australia $0.010B 0.00
Portage Biotech (PRTG) $0.010B 0.00
Turnstone Biologics (TSBX) United States $0.009B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.009B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.009B 0.00
Bionano Genomics (BNGO) United States $0.008B 0.00
Aytu BioPharma (AYTU) United States $0.007B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.007B 0.00
Biofrontera (BFRI) United States $0.007B 0.00
Hoth Therapeutics (HOTH) United States $0.007B 0.00
Cyclerion Therapeutics (CYCN) United States $0.007B 0.00
Apollomics (APLM) United States $0.007B 0.00
Aptose Biosciences (APTO) Canada $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
Dogwood Therapeutics (DWTX) United States $0.007B 0.00
BioXcel Therapeutics (BTAI) United States $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.006B 0.00
Alzamend Neuro (ALZN) United States $0.006B 0.00
Dermata Therapeutics (DRMA) United States $0.006B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
Soligenix (SNGX) United States $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
Onconetix (ONCO) United States $0.005B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.005B 0.00
Adial Pharmaceuticals (ADIL) United States $0.004B 0.00
Allarity Therapeutics (ALLR) United States $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
BioAffinity Technologies (BIAF) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Novogen (KZIA) Australia $0.004B 0.00
Organovo Holdings (ONVO) United States $0.004B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.004B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.004B 0.00
Ensysce Biosciences (ENSC) United States $0.004B 0.00
Purple Biotech (PPBT) Israel $0.004B 0.00
Pasithea Therapeutics (KTTA) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.003B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.003B 0.00
Titan Pharmaceuticals (TTNP) United States $0.003B 0.00
180 Life Sciences (ATNF) United States $0.003B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Artelo Biosciences (ARTL) United States $0.003B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Revelation Biosciences (REVB) United States $0.002B 0.00
Sunshine Biopharma (SBFM) United States $0.002B 0.00
NuCana (NCNA) United Kingdom $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Evaxion Biotech (EVAX) Denmark $0.002B 0.00
GENPREX (GNPX) United States $0.002B 0.00
Ocean Biomedical (OCEA) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
GRI Bio (GRI) United States $0.002B 0.00
Polyrizon (PLRZ) Israel $0.002B 0.00
Eyenovia (EYEN) United States $0.002B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.001B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.001B 0.00
Atrinsic (PTIX) United States $0.001B 0.00
NAYA Biosciences (NAYA) United States $0.001B 0.00
Mustang Bio (MBIO) United States $0.001B 0.00
Vincerx Pharma (VINC) United States $0.001B 0.00
Eterna Therapeutics (ERNA) United States $0.001B 0.00
Enveric Biosciences (ENVB) United States $0.001B 0.00
Windtree Therapeutics (WINT) United States $0.001B 0.00
Capstone Therapeutics (CAPS) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00